Radioligand Therapy with [(177)Lu]Lu-DOTA-TATE or [(177)Lu]Lu-DOTA-TATE and [(90)Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 Grade

Background: Neuroendocrine neoplasms (NENs) are a rare group of tumors with a different clinical course, prognosis and location. Radioligand therapy (RLT) can be used as a first or second line of treatment. It is registered in gastroenteropancreatic NENs (GEP-NENs) as grades G1 and G2. Tumors with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Durma, Adam Daniel, Saracyn, Marek, Kołodziej, Maciej, Jóźwik-Plebanek, Katarzyna, Dmochowska, Beata, Mróz, Adrianna, Żmudzki, Wawrzyniec, Kamiński, Grzegorz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537132/
https://www.ncbi.nlm.nih.gov/pubmed/37765013
http://dx.doi.org/10.3390/ph16091205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537132/
https://www.ncbi.nlm.nih.gov/pubmed/37765013
http://dx.doi.org/10.3390/ph16091205

Ejemplares similares